Temporal differences in gamma-hydroxybutyrate overdoses involving injecting drug users versus recreational drug users in Helsinki : a retrospective study by Boyd, James J. et al.
ORIGINAL RESEARCH Open Access
Temporal differences in gamma-hydroxybutyrate
overdoses involving injecting drug users versus
recreational drug users in Helsinki: a retrospective
study
James J Boyd1*, Markku J Kuisma1 and Tarja T Randell2
Abstract
Background: Gamma-hydroxybutyrate (GHB) and gamma-butyrolactone (GBL) have been profiled as ‘party drugs’
used mainly at dance parties and in nightclubs on weekend nights. The purpose of this study was to examine the
frequency of injecting drug use among GHB/GBL overdose patients and whether there are temporal differences in
the occurrence of GHB/GBL overdoses of injecting drug and recreational drug users.
Methods: In this retrospective study, the ambulance and hospital records of suspected GHB- and GBL overdose
patients treated by the Helsinki Emergency Medical Service from January 1st 2006 to December 31st 2007 were
reviewed. According to the temporal occurrence of the overdose, patients were divided in two groups. In group A,
the overdose occurred on a Friday-Saturday or Saturday-Sunday night between 11 pm-6 am. Group B consisted of
overdoses occurring on outside this time frame.
Results: Group A consisted of 39 patient contacts and the remaining 61 patient contacts were in group B. There
were statistically significant differences between the two groups in (group A vs. B, respectively): history of injecting
drug abuse (33% vs. 59%, p = 0.012), reported polydrug and ethanol use (80% vs. 62%, p = 0.028), the location
where the patients were encountered (private or public indoors or outdoors, 10%, 41%, 41% vs. 25%, 18%, 53%, p
= 0.019) and how the knowledge of GHB/GBL use was obtained (reported by patient/bystanders or clinical
suspicion, 72%, 28% vs. 85%, 10%, p = 0.023). Practically all (99%) patients were transported to emergency
department after prehospital care.
Conclusion: There appears to be at least two distinct groups of GHB/GBL users. Injecting drug users represent the
majority of GHB/GBL overdose patients outside weekend nights.
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Background
Gamma-hydroxybutyrate (GHB) and gamma-butyrolac-
tone (GBL) have been profiled as ‘party drugs’ used
mainly at dance parties, in nightclubs or other similar
settings [1-4]. They have also been used by bodybuilders
and to facilitate sexual assault [3]. The effects of GHB/
GBL range from euphoria, disinhibition and agitation to
reduced level of consciousness, respiratory depression
and death [3].
The Helsinki Emergency Medical Services (EMS)
encounters GHB/GBL overdose patients outside the
more conventional setting of weekend nights. Also,
many of the patients have a history of injecting drug
use. The aims of this study were to examine the propor-
tion of patients with GHB/GBL overdose presenting to
the EMS outside weekend nights and the frequency of
injecting drug use among GHB/GBL overdose patients.* Correspondence: james.boyd@hus.fi
1Helsinki Emergency Medical Service, Helsinki University Central Hospital,
Helsinki, Finland
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Methods
The study plan and hypothesis were retrospective,
although data were collected prospectively for quality
assurance purposes. Helsinki, the capital city of Finland
had a population of 560,000 during the study period.
Helsinki consist of both urban and semi-urban areas.
The Helsinki EMS responds to all urgent calls in the
city and is composed of a three tiered system. The first
tier consisting of emergency medical technician (EMT),
trained firemen manning the ambulances and fire
engines used as first responding units. The second tier
consists of three advanced life support (ALS) units
manned by paramedics and one paramedic supervisor
unit. The paramedics are licensed to administer intrave-
nous drugs after physician consultation or by following
written standing orders. The third tier is made up of a
mobile intensive care unit (MICU) staffed by two EMT-
firemen and an emergency physician. One emergency
physician is on-call at a time. The on-call physician is
responsible for consulting both EMS personnel and pri-
vate ambulance company personnel and participates in
the care of high-risk patients personally.
Institutional approval was obtained. The EMS records
of patients with serious presumed GHB or GBL over-
doses were collected prospectively on-line by the on-call
emergency physician and reviewed by one of the authors
(JB) from January 1st 2006 to December 31st 2007. All
applicable cases from this time period were included in
the study. We defined a presumed GHB/GBL overdose
as any patient with either reported use of GHB/GBL or
clinical findings suggesting GHB/GBL overdose and
GHB/GBL found on person. Clinical findings suggesting
a GHB/GBL overdose were considered to be: a reduced
level of consciousness with periods of agitation, respira-
tory depression and bradycardia [3,4]. The recognition
of a GHB overdose by clinical signs and symptoms has
been previously shown to be reliable with a sensitivity of
97% and specificity of 91% [2]. Clinical suspicion of
GHB intoxication has been used as an inclusion criteria
also in a previous study [5]. An overdose was considered
to be serious if the patient had a reduced level of con-
sciousness and/or respiratory depression.
The patients were then divided in to two groups
according to the time of call to the emergency dispatch-
ing centre. In group A, the call was made on Friday-
Saturday or Saturday-Sunday between 11 p.m. and 6 a.
m. In group B, the call was made outside this time
frame. In a previous study on patients attending an
emergency department (ED) after GHB ingestion, the
majority (54%) of the patients attended the ED between
12 midnight and 8 a.m. [5]. In the present study, the
time of the call to the emergency dispatching centre was
used instead of ED attendance time. As this time would
precede the time of attendance to an ED, the timeframe
of 11 p.m. and 6 a.m. was used. Especially Friday and
Saturday nights were described as “party” nights, a
potential time for recreational drug use, in a previous
study on club drug use (e.g. GHB) [6].
For each patient, we recorded the date and time of the
call to the emergency dispatching centre, age, sex, loca-
tion of the overdose, previous substance abuse, agents
involved in current overdose, level of consciousness and
respiration on arrival of the first responding unit and
after treatment, treatment provided by the EMS person-
nel and disposition of the patient. When considering the
location of the overdose, a private residence was marked
as ‘private, indoors’. Bars, restaurants, discos, night-clubs
and metro-stations were marked as ‘public, indoors’ and
streets, parks or vehicles were marked as ‘outdoors’.
When possible, alcohol breath analyzers were used in
the prehospital phase (Dräger alcotest 6510, Drägerwerk
AG & Co. KGaA 23542 Lübeck, Germany). Hospital
records were reviewed for conformation of the diagnosis
of GHB/GBL overdose, level of care required in the
emergency department (ED), disposition and previous
substance abuse.
Chi-square and Mann-Whitney tests were used when
appropriate. p-value less than 0.05 was considered statis-
tically significant. Statistics were calculated using SPSS
statistical software (SPSS for Windows version 16.0,
SPSS Inc., Chicago, IL).
Results
Helsinki EMS ambulances were dispatched to 40,993
urgent calls in 2006. Out of these, 2952 were coded as
intoxications or overdoses. In 2007, the respective fig-
ures were 46,102 and 3089. In addition to GHB and
GBL overdoses, the Helsinki EMS treated 24 and 26
non-fatal presumed opioid overdoses in 2006 and 2007,
respectively. Two patients had used GBL and alcohol
with crushed, dissolved and injected buprenorphine
tablets. They had the clinical picture of an opioid over-
dose and responded to naloxone.
During the study period there were 100 GHB/GBL
overdoses involving 90 patients. Eight patients were
treated more than once. Forty one patients had a history
of injecting drug use according to the hospital records
and thirteen had also previous GHB/GBL use. The his-
tory of injecting drug use included amphetamine (n =
19), buprenorphine (n = 10), heroin (n = 3) and unspe-
cified injected drugs (n = 19). In addition, alcohol and
benzodiazepines were widely used. During the study
period, EMS treated four of these patients twice and
two patients three times due to GHB/GBL overdose.
Forty nine patients did not have previous injecting drug
use recorded, but seven had previous GHB/GBL use
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according to hospital records. Two of these patients
were treated twice by EMS due to GHB/GBL overdose
during the study period.
The annual occurrence of GHB/GBL overdoses trea-
ted by EMS increased from 32 patient contacts in 2006
to 68 patient contacts in 2007. Among these, GHB/GBL
overdoses involving injecting drug users increased from
18 to 31 patient contacts during the same time period.
The temporal distribution of all the patient contacts
according to the weekday and the time of day are pre-
sented in Figures 1 and 2, respectively. The call to the
emergency dispatching centre was placed on Friday-
Saturday or Saturday-Sunday night between 11 pm-6
am in thirty nine patient contacts (Group A). The
majority, sixty one, of the patient contacts were outside
this time frame (Group B). Almost all the patients were
encountered either from the city centre or an area
North-east of the city centre (Kallio) or in their immedi-
ate vicinity.
Patient characteristics are presented in table 1 and
concomitantly used drugs and medications are presented
in Figures 3 and 4. There were statistically significant
differences between the two groups in history of inject-
ing drug use (p = 0.012) and reported concomitant use
of other drugs, medications and/or ethanol; 31 (80%)
patients in group A versus 38 (62%) patients in group B,
p = 0.028.
No statistically significant differences were noted in
the EMS use of prehospital naloxone and flumazenil
between the two groups (p = 0.083). In group A, nalox-
one was not administered, but flumazenil was adminis-
tered to six patients. In group B, both naloxone and
flumazenil were administered to one patient and nalox-
one or flumazenil alone was administered to five
patients, respectively. There was no difference in intuba-
tion rate between the two groups (Table 1).
Between the two groups, there were also statistically
significant differences in the location where the patients
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Figure 1 Distribution of overdoses according to the weekday. Patients with serious GHB and GBL overdose treated by Helsinki EMS in 2006-
2007. EMS: Emergency Medical Service, GHB: gammahydroxybutyrate, GBL: gammabutyrolactone.
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were encountered (private or public indoors or out-
doors, p = 0.019, Figures 5 and 6) and how the knowl-
edge of GHB/GBL use was obtained (self reported,
reported by bystanders or clinical suspicion, p = 0.023
(Figures 7 and 8). There was no difference between the
two groups in the caller to the emergency dispatching
centre (p = 0.687, Figures 9 and 10). Practically all
(99%) patients were transported after prehospital care to
one of the three local EDs.
Discussion
In our investigation, the majority (60%) of GHB/GBL
overdoses occurred from 11 p.m. to 6 a.m. and 55%
occurred during weekend from Friday evening to Sun-
day (Figure 1 and 2). Similar findings have been
reported previously [5,7], with up to 92% of the patients
arriving to an ED between Friday 5 p.m. and Monday 8
a.m. [8]. These findings are probably related to the role
of GHB/GBL as a recreational drug [1-3]. Among inject-
ing heroin users, similar concentration on weekends has
been found in overdoses [9], but in comparison to GHB
users most the heroin overdoses occurred in the early
evening or before midnight [9,10]. Patients were predo-
minately encountered in areas were the city’s night life
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Figure 2 Distribution of overdoses according to the time of day. Patients with serious GHB and GBL overdose treated by Helsinki
Emergency Medical Services in 2006-2007. EMS: Emergency Medical Service, GHB: gammahydroxybutyrate, GBL: gammabutyrolactone.
Table 1 Patient characteristics and prehospital airway
management.
Group A Group B p-value
n 39 (39%) 61 (61%)
Sex (male) 19 (49%) 35 (57%) 0.397
Age* 24 (22;27) 25 (23;29) 0.134
History of injecting drug use 13 (33%) 36 (59%) 0.012
Intubated by EMS on scene 8 (21%) 14 (23%) 0.774
Patients with serious GHB and GBL overdose treated by Helsinki EMS in 2006-
2007.
*Median and 25- and 75-percentiles.
Group A: call to emergency dispatching centre made on Friday-Saturday or
Saturday-Sunday night between 11 pm and 6 am. Group B: call to emergency
dispatching centre made at other times.
GHB: gammahydroxybutyrate, GBL: gammabutyrolactone, EMS: Emergency
Medical Service.
Boyd et al. Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine 2012, 20:7
http://www.sjtrem.com/content/20/1/7
Page 4 of 10
is concentrated (city centre, Kallio) or where substance
abuse is popular (Kallio).
In the present study, 54% of all the patients and 49%
of patients in group A were male. This is lower than in
some of the previous studies, where 60-93% of the
GHB-related medical emergency patients were male
[1,4,5,8,11]. The higher portion of males could be
related to the high popularity of GHB/GBL amongst
homosexual men in the study populations [4,6,11]. Yet,
some studies on another recreational drug, MDMA
(’Ecstasy’ or 3,4-methylenedioxymethamphetamine),
have failed to show gender differences in use [12,13].
Females also suffer from acute adverse effects of drug
abuse more often as they usually dose at similar rates as
men while being of smaller size and having different
physiology [14]. Also, among suspected exposures to
GHB and congener drugs reported to the California Poi-
son Control System the proportion of women increased
from 38% in 1999 to 60% in 2003 [15]. However, this
increase could be partly explained by the proportional
increase of ‘malicious’ events, such as sexual assaults,
where the majority of victims were female [15].
There appears to be at least two distinct groups of
GHB/GBL users. The majority of the patients in group
A used GHB/GBL with alcohol and overdosed during
weekend nights in night-clubs and discos (public places).
On the other hand, the majority of the patients in group
B had a history of injecting drug use, overdosed in the
middle of the week or in the early evenings and were
encountered more often in private residences and out-
doors (Tables 1, Figures 5 and 6). Injecting drug users
also had more often repeated GHB/GBL overdoses in
comparison to non injecting drug users. Similar differ-
ences in the relative location of the overdose have been
noted when comparing GHB- and heroin overdose
patients previously [1].
Temporal differences in GHB/GBL overdoses invol-
ving injecting drug users are also seen in more recent
data, although less than in 2006-2007. Between 1.1.2009
and 31.12.2010 Helsinki EMS treated 58 GHB/GBL
overdose patients. Of them, 25 (43%) had a history of
injecting drug use. During weekend nights, 36% of the
GHB/GBL overdose patients had a history of injecting
drug use, while 45% had a similar history if encountered
outside this time frame (James Boyd: Personal commu-
nication). These findings could reflect decreased use of
GHB/GBL by injecting drug users. This is supported by
a recent study on disadvantaged drug users in Helsinki,
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Figure 3 Concomitantly used substances in group A. Patients with serious GHB and GBL overdose treated by Helsinki EMS in 2006-2007. Call
to emergency dispatching centre made on Friday-Saturday or Saturday-Sunday night between 11 pm and 6 am. EMS: Emergency Medical
Service, MDMA: 3,4-methylenedioxymethamphetamine.
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Figure 4 Concomitantly used substances in group B. Patients with serious GHB and GBL overdose treated by Helsinki EMS in 2006-2007.
Group B: call to emergency dispatching centre made outside the time frame of weekend nights. EMS: Emergency Medical Service, MDMA: 3, 4-
methylenedioxymethamphetamine.
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16; 41 %
16; 41 %
3; 8 %
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-not recorded
Figure 5 Location of overdose in group A. Patients with serious GHB and GBL overdose treated by Helsinki EMS in 2006-2007. Group A: call
to emergency dispatching centre made on Friday-Saturday or Saturday-Sunday night between 11 pm and 6 am. EMS: Emergency Medical
Service, GHB: gammahydroxybutyrate, GBL: gammabutyrolactone.
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15; 25 %
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32; 52 %
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Figure 6 Location of overdose in group B. Patients with serious GHB and GBL overdose treated by Helsinki EMS in 2006-2007. Group B: call to
emergency dispatching centre made outside the time frame of weekend nights. EMS: Emergency Medical Service, GHB: gammahydroxybutyrate,
GBL: gammabutyrolactone.
28; 72 %
11; 28 %
0; 0 %
-history (self, friends)
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-not recorded
Figure 7 Information on GHB or GBL use in group A. Patients with serious GHB and GBL overdose treated by Helsinki EMS in 2006-2007.
Group A: call to emergency dispatching centre made on Friday-Saturday or Saturday-Sunday night between 11 pm and 6 am. EMS: Emergency
Medical Service, GHB: gammahydroxybutyrate, GBL: gammabutyrolactone.
Boyd et al. Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine 2012, 20:7
http://www.sjtrem.com/content/20/1/7
Page 7 of 10
52; 85 %
6; 10 %
3; 5 %
-history (self, friends)
-signs and symptoms and
GHB/GBL found on person
-not recorded
Figure 8 Information on GHB or GBL use in group B. Patients with serious GHB and GBL overdose treated by Helsinki EMS in 2006-2007.
Group B: call to emergency dispatching centre made outside the time frame of weekend nights. EMS: Emergency Medical Service, GHB:
gammahydroxybutyrate, GBL: gammabutyrolactone.
16; 41 %
8; 21 %
11; 28 %
4; 10 %
- friend, relative
-by passer
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Figure 9 Caller to emergency dispatching centre in group A. Patients with serious GHB and GBL overdose treated by Helsinki EMS in 2006-
2007. Group A: call to emergency dispatching centre made on Friday-Saturday or Saturday-Sunday night between 11 pm and 6 am. EMS:
Emergency Medical Service, GHB: gammahydroxybutyrate, GBL: gammabutyrolactone.
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where 6% of the interviewed reported use of GHB/GBL
within the past month, while 22% reported use over 12
months previously [16]. To our knowledge, the occur-
rence of GHB/GBL overdoses that involve injecting drug
users has not been previously reported.
Polysubstance use is common with GHB use
[2-5,8,11]. Polydrug use, as such, was less often reported
in group B (Figures 3 and 4). This could be due to the
concomitant use of other, more illegal substances, by
injecting drug users and thus unwillingness to report
them. Also, although there were no statistically signifi-
cant differences, naloxone and flumazenil were adminis-
tered by EMS more often in this group.
Users of amphetamine, buprenorphine and heroin
typically inject their drugs in Finland [16,17]. Since the
beginning of the century there has been a remarkable
decline in heroin related overdoses in Finland [18],
while buprenorphine abuse has increased [17,19]. In
2007, the number of GHB/GBL overdose patient con-
tacts, with a history of injecting drug use, surpassed that
of opioid overdose patient contacts (31 vs. 26, respec-
tively) in our study population.
As polydrug use is very common among injecting
drug users in Finland to begin with [16,17] and GHB/
GBL are relatively easy to obtain and cheap (a 50 ml
bottle costs 5-6 €) to our knowledge, it is easy to see
the potential of it as a drug of abuse also among inject-
ing drug users. Almost one third of the patients with a
history of injecting drug abuse also had a history of pre-
vious GHB/GBL use. This could implicate chronic use
of GHB/GBL among this group of patients.
The clinical implications are that a GHB/GBL over-
dose patient encountered during weekdays has more
probably a history of injecting drug use with all the
related medical and social problems, such as a higher
risk for infectious diseases [20,21] and homelessness
[21]. Also, the possibility of a GHB/GBL overdose
should be kept in mind when treating injecting drug
users with a reduced level of consciousness and respira-
tory depression, even when evidence of currently admi-
nistered injectable substances is present.
Study limitations
The patients in this study do not represent all the
patients with GHB/GBL related problems treated by the
Helsinki EMS. Probably both the non severe cases and
some of the unconscious patients were missed due to
the lack of knowledge on GHB/GBL involvement. In
25; 41 %
9; 15 %
21; 34 %
6; 10 %
- friend, relative
-by passer
-police 
-not recorded
Figure 10 Caller to emergency dispatching centre in group B. Patients with serious GHB and GBL overdose treated by Helsinki EMS in 2006-
2007. Group B: call to emergency dispatching centre made outside the time frame of weekend nights. EMS: Emergency Medical Service, GHB:
gammahydroxybutyrate, GBL: gammabutyrolactone.
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addition, injecting drug users are unlikely to call for
help when an overdose occurs [22], so at least part of
their GHB/GBL related overdoses went unnoticed by
EMS. When considering the temporal distribution, it
should be noted that festivities (such as New Year’s Eve,
Christmas, 1st of May, Midsummer) were not
considered.
There was no toxicological confirmation on GHB/GBL
use. The GHB/GBL use was, however, mainly reported
by the overdose victims themselves or by bystanders.
Only in a minority of cases clinical suspicion with liquid
suspected to be GHB or GBL found on person was used
as a criteria for inclusion (Figures 7 and 8). The conco-
mitant use of other substances was self reported or
reported by bystanders, except for ethanol (alcohol
breath analyzers were routinely used).
Conclusion
There appears to be at least two distinct groups of
GHB/GBL users. Recreational drug users use GHB/GBL
with alcohol and overdose during weekend nights while
clubbing. Patients with a history of injecting use of
amphetamines, heroin and/or buprenorphine represent
the majority of GHB/GBL overdose patients outside
weekend nights.
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